RCMNY
WGS icon

Rubric Capital Management (New York)’s GeneDx Holdings WGS Stock Holding History

Rubric Capital Management (New York)’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-757
Closed -$111K – 81
2021
Q4 		$111K Buy
+757
New +$169K 0.01% 68

Other funds holding WGS

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Rubric Capital Management (New York)'s WGS Position: Q1 2022 in Review

Rubric Capital Management (New York) sold out of GeneDx Holdings (WGS) in Q1 2022, closing a stake of 757 shares — an estimated $111K sold.

Rubric Capital Management (New York) first reported a position in WGS in Q4 2021 and held it in 1 quarter. The position peaked at $111K in Q4 2021. 108 funds tracked by Wall St. Rank hold WGS as of Q1 2022.

  • Rubric Capital Management (New York) reported no remaining GeneDx Holdings position as of Q1 2022 after selling out during the quarter.
  • Rubric Capital Management (New York) sold 757 GeneDx Holdings shares in Q1 2022, an estimated $111K.
  • Rubric Capital Management (New York) first reported a position in GeneDx Holdings in Q4 2021 and held it in 1 quarter.
  • Rubric Capital Management (New York)'s GeneDx Holdings position peaked at $111K in Q4 2021.
  • 108 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2022.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2022, filed 13 May 2022.